Lantern Pharma Incis A Clinical Stage Biotechnology Company Focused On Advancing Oncology Drug Development Through Ai Driven Precision Medicinethe Company Utilizes Its Proprietary Radraplatformwhich Analyzes Over 100 Billion Oncology Focused Data Points And Employs More Than 200 Machine Learning Algorithmsthis Technology Helps Identify Drug Response Biomarkersoptimize Drug Candidatesand Rescue Previously Failed Compoundsaiming To Reduce Development Timelines And Costs Lantern Pharma S Product Pipeline Includes Three Lead Drug Candidates And An Antibody Drug Conjugate Program Targeting Twelve Cancer Indicationsthe Company Is Currently Conducting Mid Stage Trials For One Candidate And Has Initiated Two Phase 1 Trials For Additional Candidatestheir Approach Emphasizes Precision Medicinetargeting Specific Patient Subgroups Most Likely To Benefit From Their Therapiescollaborations With Academic Institutions And Industry Partners Support The Validation And Advancement Of Their Drug Candidates
